ID   RNLS_RAT                Reviewed;         315 AA.
AC   Q5U2W9;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   29-MAY-2024, entry version 112.
DE   RecName: Full=Renalase;
DE            EC=1.6.3.5 {ECO:0000250|UniProtKB:Q5VYX0};
DE   AltName: Full=Monoamine oxidase-C;
DE            Short=MAO-C;
DE   AltName: Full=alpha-NAD(P)H oxidase/anomerase;
DE   Flags: Precursor;
GN   Name=Rnls;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION.
RX   PubMed=15841207; DOI=10.1172/jci24066;
RA   Xu J., Li G., Wang P., Velazquez H., Yao X., Li Y., Wu Y., Peixoto A.,
RA   Crowley S., Desir G.V.;
RT   "Renalase is a novel, soluble monoamine oxidase that regulates cardiac
RT   function and blood pressure.";
RL   J. Clin. Invest. 115:1275-1280(2005).
RN   [3]
RP   FUNCTION.
RX   PubMed=18299506; DOI=10.1161/circulationaha.107.732032;
RA   Li G., Xu J., Wang P., Velazquez H., Li Y., Wu Y., Desir G.V.;
RT   "Catecholamines regulate the activity, secretion, and synthesis of
RT   renalase.";
RL   Circulation 117:1277-1282(2008).
CC   -!- FUNCTION: Catalyzes the oxidation of the less abundant 1,2-dihydro-
CC       beta-NAD(P) and 1,6-dihydro-beta-NAD(P) to form beta-NAD(P)(+) (By
CC       similarity). The enzyme hormone is secreted by the kidney, and
CC       circulates in blood and modulates cardiac function and systemic blood
CC       pressure. Lowers blood pressure in vivo by decreasing cardiac
CC       contractility and heart rate and preventing a compensatory increase in
CC       peripheral vascular tone, suggesting a causal link to the increased
CC       plasma catecholamine and heightened cardiovascular risk. High
CC       concentrations of catecholamines activate plasma renalase and promotes
CC       its secretion and synthesis. {ECO:0000250|UniProtKB:Q5VYX0,
CC       ECO:0000269|PubMed:15841207, ECO:0000269|PubMed:18299506}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:40395, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88138; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q5VYX0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:40399, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88137; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q5VYX0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NADP + H(+) + O2 = H2O2 + NADP(+);
CC         Xref=Rhea:RHEA:48000, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:58349, ChEBI:CHEBI:88139; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q5VYX0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,6-dihydro-beta-NAD + H(+) + O2 = H2O2 + NAD(+);
CC         Xref=Rhea:RHEA:47996, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:57540, ChEBI:CHEBI:88140; EC=1.6.3.5;
CC         Evidence={ECO:0000250|UniProtKB:Q5VYX0};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the renalase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085833; AAH85833.1; -; mRNA.
DR   RefSeq; NP_001014189.1; NM_001014167.1.
DR   AlphaFoldDB; Q5U2W9; -.
DR   SMR; Q5U2W9; -.
DR   STRING; 10116.ENSRNOP00000028098; -.
DR   PhosphoSitePlus; Q5U2W9; -.
DR   PaxDb; 10116-ENSRNOP00000028098; -.
DR   Ensembl; ENSRNOT00000028098.6; ENSRNOP00000028098.5; ENSRNOG00000020705.6.
DR   GeneID; 361751; -.
DR   KEGG; rno:361751; -.
DR   UCSC; RGD:1309804; rat.
DR   AGR; RGD:1309804; -.
DR   CTD; 55328; -.
DR   RGD; 1309804; Rnls.
DR   eggNOG; ENOG502QUZR; Eukaryota.
DR   GeneTree; ENSGT00390000016052; -.
DR   HOGENOM; CLU_036034_1_0_1; -.
DR   InParanoid; Q5U2W9; -.
DR   OMA; ICGGDAF; -.
DR   OrthoDB; 5394503at2759; -.
DR   PhylomeDB; Q5U2W9; -.
DR   TreeFam; TF332799; -.
DR   BRENDA; 1.6.3.5; 5301.
DR   Reactome; R-RNO-197264; Nicotinamide salvaging.
DR   PRO; PR:Q5U2W9; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020705; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0051379; F:epinephrine binding; ISO:RGD.
DR   GO; GO:0097621; F:monoamine oxidase activity; ISO:RGD.
DR   GO; GO:0070404; F:NADH binding; ISO:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; ISO:RGD.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; ISO:RGD.
DR   GO; GO:0003214; P:cardiac left ventricle morphogenesis; ISO:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; ISO:RGD.
DR   GO; GO:0042414; P:epinephrine metabolic process; ISO:RGD.
DR   GO; GO:0060047; P:heart contraction; ISO:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; ISO:RGD.
DR   GO; GO:0010459; P:negative regulation of heart rate; ISO:RGD.
DR   GO; GO:0042415; P:norepinephrine metabolic process; ISO:RGD.
DR   GO; GO:0055062; P:phosphate ion homeostasis; ISO:RGD.
DR   GO; GO:0003073; P:regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0071869; P:response to catecholamine; IEP:RGD.
DR   GO; GO:0071871; P:response to epinephrine; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0071873; P:response to norepinephrine; ISO:RGD.
DR   GO; GO:1902074; P:response to salt; IDA:RGD.
DR   Gene3D; 3.90.660.10; -; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 1.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR040174; RNLS.
DR   PANTHER; PTHR23357:SF1; RENALASE; 1.
DR   PANTHER; PTHR23357; UNCHARACTERIZED; 1.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   Pfam; PF13450; NAD_binding_8; 1.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
PE   2: Evidence at transcript level;
KW   FAD; Flavoprotein; NAD; NADP; Oxidoreductase; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..315
FT                   /note="Renalase"
FT                   /id="PRO_0000019589"
FT   BINDING         12
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   BINDING         42
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   BINDING         61..62
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   315 AA;  34951 MW;  C4B606AC2F421698 CRC64;
     MFRVLVVGAG LTGSLCAALL RKEITAPLYL ALWDKAGDIG GRMTTANSPH NPRCTADLGA
     QYITCTPHYA KKHQNFYEEL LAHGILEPLT SPIKGMEVKE GESNFVAPHG VSSIIKYYLK
     ESGAEVFLRQ CVTQINLRDN KWEVSEDTGS TQQFDLVILT MPAPQILGLQ GDIVNLISER
     QRQQLASVSY SSRYALGLFY EAGMKIDVPW AGQYITSNPC IRFISIDSKK RNTESSECGP
     LLVVHTTVPF GVTHLEHSEE DVQELITQQL ETILPGLPPP VATKCWKWRY SQVTNSAANS
     PGQMTLHLNP FLIYI
//
